Mercury Systems (MRCY) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
16 Jan, 2026Executive summary
Q1 FY25 revenue rose 13% year-over-year to $204.4M, with bookings of $247.7M, a 29% increase and a book-to-bill ratio of 1.21.
Net loss narrowed to $17.5M from $36.7M year-over-year, with adjusted EBITDA at $21.5M and adjusted EPS at $0.04.
Record backlog reached over $1.3B, up 16% year-over-year, with $777M expected to convert to revenue within 12 months.
Operating expenses and net working capital decreased year-over-year, supporting margin expansion and improved free cash flow.
Cost reductions from workforce actions led to lower SG&A and R&D expenses.
Financial highlights
Revenue: $204.4M, up $23.4M (13%) year-over-year.
Bookings: $247.7M, up 29% year-over-year; book-to-bill ratio 1.21.
Adjusted EBITDA: $21.5M (10.5% margin), up from $2.0M (1.1%) year-over-year.
Free cash flow: $(20.9)M, improved from $(47.1)M year-over-year.
GAAP net loss: $17.5M ($0.30 per share), improved from $36.7M ($0.64 per share) last year.
Adjusted EPS: $0.04, up from $(0.24) last year.
Gross margin: 25.3%, down from 27.9% year-over-year.
Outlook and guidance
FY25 revenue expected to be relatively flat year-over-year, with a stronger exit run rate.
Adjusted EBITDA margins anticipated in the low double digits for FY25, expanding in the second half.
Free cash flow expected to be positive for FY25, with stronger performance in the second half.
Management expects predictable organic growth, expanding margins, and robust free cash flow.
No specific quantitative guidance provided this early in the year.
Latest events from Mercury Systems
- Record backlog and strong cash flow highlight momentum and growth in defense technology.MRCY
Investor presentation16 Mar 2026 - Record backlog and margin expansion drive Q2 growth, improved profitability, and strong outlook.MRCY
Q2 20264 Feb 2026 - Record backlog and free cash flow support margin expansion and growth in FY25.MRCY
Q4 20241 Feb 2026 - Q2 FY25 saw 13% revenue growth, record free cash flow, and improved margins.MRCY
Q2 20259 Jan 2026 - Director elections, executive pay, new incentive plan, and auditor ratification headline the agenda.MRCY
Proxy Filing1 Dec 2025 - Board recommends approval of all proposals, with enhanced focus on pay-for-performance and ESG.MRCY
Proxy Filing1 Dec 2025 - Record bookings, margin expansion, and strong free cash flow set the stage for FY26 growth.MRCY
Q4 202523 Nov 2025 - Q3 FY25 saw revenue, margin, and cash flow gains, with backlog and outlook both strengthening.MRCY
Q3 202519 Nov 2025 - Revenue up 10.2% with record backlog, margin gains, and $200M buyback program announced.MRCY
Q1 202613 Nov 2025